{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:08:29Z","timestamp":1779235709378,"version":"3.51.4"},"reference-count":64,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T00:00:00Z","timestamp":1511308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"HHS","award":["HHSO1002006000017C"],"award-info":[{"award-number":["HHSO1002006000017C"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0186892","type":"journal-article","created":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T18:29:16Z","timestamp":1511375356000},"page":"e0186892","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":33,"title":["Therapeutic efficacy of equine botulism antitoxin in Rhesus macaques"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1520-5952","authenticated-orcid":true,"given":"Shantha","family":"Kodihalli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Emanuel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Takla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross","family":"LeClaire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise C.","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,11,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.285.8.1059","article-title":"Botulinum toxin as a biological weapon: medical and public health management","volume":"285","author":"SS Arnon","year":"2001","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/infdis\/jit449","article-title":"A novel strain of clostridium botulinum that produces type B and type H botulinum toxins","volume":"209","author":"JR Barash","year":"2014","journal-title":"J Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12866-015-0567-5","article-title":"Detection of the HA-33 protein in botulinum neurotoxin type G complex by mass spectrometry","volume":"15","author":"SR Kalb","year":"2015","journal-title":"BMC Micobiology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/infdis\/jiv327","article-title":"A Novel Botulinum Neurotoxin, Previously Reported as Serotype H, Has a Hybrid-Like Structure With Regions of Similarity to the Structures of Serotypes A and F and Is Neutralized With Serotype A Antitoxin","volume":"213","author":"S Maslanka","year":"2016","journal-title":"J Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.pharmtox.44.101802.121554","article-title":"Identification of the major steps in botulinum toxin actions","volume":"44","author":"LL Simpson","year":"2004","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/MMBR.46.1.86-94.1982","article-title":"Bacterial Toxins: a Table of Lethal Amounts","volume":"46","author":"MD Gill","year":"1982","journal-title":"Microbiological Reviews"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40696-016-0017-4","article-title":"Toxins as biological weapons for terror\u2014characteristics, challenges and medical countermeasures: a mini-review","volume":"2","author":"T Berger","year":"2016","journal-title":"Disaster and Military Medicine"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/bdr2.1016","article-title":"Preparing for Biological Threats: Addressing the Needs of Pregnant Women","volume":"109","author":"AK Watson","year":"2017","journal-title":"Birth Defects Research"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3201\/eid1506.070571","article-title":"Clinical recovery and circulating botulinum toxin type F in adult patient","volume":"15","author":"J Sobel","year":"2009","journal-title":"Emer Infect Dis"},{"key":"ref10","first-page":"1758","article-title":"Textbook of Pediatric Infectious Diseases","author":"SS Arnon","year":"2004"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.pediatrneurol.2015.01.006","article-title":"Infant botulism: review and clinical update","volume":"52","author":"LK Rosow","year":"2015","journal-title":"Pediatr Neurol."},{"key":"ref12","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1001\/jama.279.11.859","article-title":"Wound botulism associated with black tar heroin among injecting drug users","volume":"279","author":"DJ Passaro","year":"1998","journal-title":"JAMA"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1099\/jmm.0.05379-0","article-title":"Wound botulism in the UK and Ireland","volume":"53","author":"MM Brett","year":"2004","journal-title":"J Med Micro"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1385\/NCC:6:1:30","article-title":"Rapid geographical clustering of wound botulism in Germany after subcutaneous and intramuscular injection of heroin","volume":"6","author":"N Galldiks","year":"2007","journal-title":"Neurocrit Care"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2105\/AJPH.2011.300314","article-title":"A decade of spore-forming bacterial infections among European injecting drug users: pronounced regional variation","volume":"102","author":"VD Hope","year":"2012","journal-title":"Am J Public Health"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3201\/eid1901.120044","article-title":"Infections with spore-forming bacteria in persons who inject drugs, 2000\u20132009","volume":"19","author":"NE Palmateer","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev.biochem.051908.125345","article-title":"Botulinum Neurotoxin: A Marvel of Protein Design","volume":"79","author":"M Montal","year":"2010","journal-title":"Annu Rev Biochem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.toxicon.2013.02.014","article-title":"The life history of a botulinum toxin molecule","volume":"68","author":"L Simpson","year":"2013","journal-title":"Toxicon"},{"key":"ref19","unstructured":"CSTE Botulism Surveillance Summary 2014: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.cdc.gov\/nationalsurveillance\/pdfs\/botulism_cste_2014.pdf\" xlink:type=\"simple\">https:\/\/www.cdc.gov\/nationalsurveillance\/pdfs\/botulism_cste_2014.pdf<\/ext-link>, retrieved on Jan 13, 2017."},{"issue":"2","key":"ref20","first-page":"93","article-title":"Botulism in the United States, 1899\u20131969","volume":"93","author":"EJ Gangarosa","year":"1971"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7326\/0003-4819-129-3-199808010-00011","article-title":"Botulism in the United States: a clinical and epidemiologic review","volume":"129","author":"RL Shapiro","year":"1998","journal-title":"Ann Intern Med"},{"key":"ref22","unstructured":"CDC 2011: National Enteric Disease Surveillance: Botulism Annual Summary, 2011 <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.cdc.gov\/nationalsurveillance\/PDFs\/Botulism_CSTE_2011.pdf\" xlink:type=\"simple\">http:\/\/www.cdc.gov\/nationalsurveillance\/PDFs\/Botulism_CSTE_2011.pdf<\/ext-link>."},{"key":"ref23","first-page":"580","article-title":"Existence of type D botulism in man","volume":"142","author":"J Demarchi","year":"1958","journal-title":"Bull Acad Natl Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/infdis\/143.1.22","article-title":"Isolation of <italic>Clostridium botulinum<\/italic> type G and identification of type G botulinum toxin in humans: Report of five sudden unexpected deaths","volume":"143","author":"O Sonnabend","journal-title":"J Infect Dis"},{"key":"ref25","first-page":"55","article-title":"Botulism: The present status of the disease","volume":"195","author":"CL Hatheway","year":"1995","journal-title":"Curr Top Microbiol Immunol"},{"issue":"9","key":"ref26","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1139\/y99-089","article-title":"Retention of cleaved synaptosome-associated protein of 25 kDa (SNAP-25) in neuromuscular junctions: a new hypothesis to explain persistence of botulinum A poisoning","volume":"77","author":"DA Raciborska","year":"1999","journal-title":"Can J Physiol Pharmacol"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.neuroscience.2005.12.029","article-title":"Recovery from botulinum neurotoxin poisoning in vivo","volume":"139","author":"JE Keller","year":"2006","journal-title":"Neuroscience"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1074\/jbc.M209821200","article-title":"Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons","volume":"278","author":"PG Foran","year":"2003","journal-title":"J Biol Chem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/infdis\/166.6.1281","article-title":"Clinical and laboratory comparison of botulism from toxin types A, B, and E in the United States, 1975\u20131988","volume":"166","author":"BA Woodruff","year":"1992","journal-title":"J Infect Dis"},{"issue":"17","key":"ref30","doi-asserted-by":"crossref","first-page":"11346","DOI":"10.1073\/pnas.172229899","article-title":"Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody","volume":"99","author":"A Nowakowski","year":"2002","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/protein\/gzq111","article-title":"Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin","volume":"24","author":"C Garcia-Rodriguez","year":"2011","journal-title":"Protein Eng Des Sel"},{"key":"ref32","first-page":"86","article-title":"Isolation of nanomolar scFvs of non-human primate origin, cross-neutralizing botulinum neurotoxins A<sub>1<\/sub> and A<sub>2<\/sub> by targeting their heavy chain","volume":"15","author":"A Avril","year":"2015"},{"issue":"8","key":"ref33","doi-asserted-by":"crossref","first-page":"e0161446","DOI":"10.1371\/journal.pone.0161446","article-title":"Development of Germline-Humanized Antibodies Neutralizing Botulinum Neurotoxin A and B","volume":"11","author":"S Miethe","year":"2017","journal-title":"PLoS ONE"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1080\/19420862.2015.1082016","article-title":"Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype B","volume":"7","author":"C Rasetti-Escargueil","year":"2015","journal-title":"mAbs"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0014-4800(67)90007-X","article-title":"Experimental botulism in monkeys\u2013A clinical pathological study","volume":"6","author":"BA Herrero","year":"1967","journal-title":"Exp Mol Pathol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/mds.870030409","article-title":"Systemic toxicity of botulinum toxin by intramuscular injection in the monkey","volume":"3","author":"AB Scott","year":"1988","journal-title":"Mov Disord"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/cpt196892209","article-title":"Evaluation of botulinum antitoxin, supportive therapy, and artificial respiration in monkeys with experimental botulism","volume":"9","author":"FW Oberst","year":"1968","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.toxicon.2011.05.003","article-title":"Comparison of oral toxicological properties of botulinum neurotoxin serotypes A and B","volume":"58","author":"LW Cheng","year":"2011","journal-title":"Toxicon"},{"key":"ref39","year":"2011"},{"key":"ref40","first-page":"113","article-title":"Botulism Toxoids. Botulism: Proceeding of a Symposium","author":"MA Cardella","year":"1964"},{"key":"ref41","first-page":"96","article-title":"The laboratory nonhuman primate","author":"JD Fortman","year":"2002"},{"key":"ref42","first-page":"351","article-title":"Small Animal Clinical Nutrition","author":"RL Remillard","year":"2000"},{"key":"ref43","first-page":"35","year":"1992"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/oxfordjournals.aje.a112599","article-title":"Botulism type B: Epidemiologic aspects of an extensive outbreak","volume":"108","author":"W Terranova","year":"1978","journal-title":"Am J Epid"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"442","DOI":"10.7326\/0003-4819-95-4-442","article-title":"Clinical features of types A and B food-borne botulism","volume":"95","author":"JM Hughes","year":"1981","journal-title":"Ann Intern Med"},{"key":"ref46","first-page":"1735","article-title":"Botulism caused by inhalation","volume":"41","author":"E Holzer","year":"1962","journal-title":"Med Klin"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM197311082891904","article-title":"Epidemiologic, clinical and laboratory aspects of wound botulism","volume":"289","author":"MH Merson","year":"1973","journal-title":"N Engl J Med"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1099\/00222615-40-6-379","article-title":"Retrospective study of 108 cases of botulism in Poitiers, France","volume":"40","author":"P Roblot","year":"1994","journal-title":"J Med Microbiol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1086\/422318","article-title":"Signs and symptoms predictive of death in patients with foodborne botulism\u2013Republic of Georgia, 1980\u20132002","volume":"39","author":"JK Varma","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1001\/jama.296.20.2476","article-title":"Botulism in 4 adults following cosmetic injections with an unlicensed, highly concentrated botulinum preparation","volume":"296","author":"DS Chertow","year":"2006","journal-title":"JAMA"},{"key":"ref51","first-page":"473","article-title":"Botulism and Tetanus neurotoxin","author":"Dr Franz","year":"1993"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1124\/jpet.106.104661","article-title":"An initial assessment of the systemic pharmacokinetics of botulinum toxin","volume":"318","author":"E Ravichandran","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"ref53","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1128\/IAI.00405-09","article-title":"Antibody protection against botulinum neurotoxin intoxication in mice","volume":"77","author":"LW Cheng","year":"2009","journal-title":"Infect Immun"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/0002-9343(84)90988-4","article-title":"Equine antitoxin use and other factors that predict outcome in type foodborne botulism","volume":"76","author":"CO Tacket","year":"1984","journal-title":"Am J Med"},{"issue":"3","key":"ref55","first-page":"219","article-title":"Structure, activity, and immune (T and B cell) recognition of botulinum neurotoxins","volume":"19","author":"MZ Atassi","year":"1999","journal-title":"Crit Rev Immunol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1086\/508176","article-title":"An outbreak of botulism in Thailand: Clinical manifestations and management of severe respiratory failure","volume":"43","author":"S Kongsaengdao","year":"2006","journal-title":"CID"},{"key":"ref57","first-page":"251","article-title":"Wound botulism in injection drug users: Time to antitoxin correlates with intensive care unit length of stay","volume":"10","author":"SR Offerman","year":"2009","journal-title":"West J Emerg Med"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1378\/chest.120.2.562","article-title":"Clinical predictors of respiratory failure and long-term outcome in black tar heroin-associated wound botulism","volume":"120","author":"CE Sandrock","year":"2001","journal-title":"Chest"},{"issue":"29","key":"ref59","first-page":"802","article-title":"Notes from the Field: Large Outbreak of Botulism Associated with a Church Potluck Meal\u2014Ohio, 2015","volume":"64","author":"CL McCarty","year":"2015","journal-title":"Weekly"},{"key":"ref60","first-page":"849","article-title":"Harrison&apos;s Principles of Internal Medicine","author":"MG Koenig","year":"1974"},{"key":"ref61","first-page":"473","article-title":"Human botulism caused by clostridium botulism type E: The Birmingham outbreak","volume":"48","author":"AP Ball","year":"1979","journal-title":"Q J Med"},{"issue":"8673","key":"ref62","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0140-6736(89)91822-9","article-title":"Slow recovery from severe foodborne botulism","volume":"2","author":"JG Colebatch","year":"1989","journal-title":"Lancet"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1128\/JCM.43.8.4280-4282.2005","article-title":"First case of infant botulism caused by <italic>Clostridium baratii<\/italic> type F in California","volume":"43","author":"JR Barash","year":"2005","journal-title":"J Clin Microbiol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1056\/NEJMoa051926","article-title":"Human Botulism Immune Globulin for the treatment of infant botulism","volume":"354","author":"SS Arnon","year":"2006","journal-title":"N Engl J Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0186892","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T15:46:31Z","timestamp":1603381591000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0186892"}},"subtitle":[],"editor":[{"given":"Michel R.","family":"Popoff","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,11,22]]},"references-count":64,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,11,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0186892","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,22]]}}}